Infectious Disease
-
Older adults first in line for RSV vaccines, but will they roll up their sleeves?
August 03, 2023 12 min read Source/Disclosures Published by: Source: Healio Interviews Disclosures: Cohn, Iroku-Malize, Nace and Schaffner report no…
Read More » -
Leprosy cases in Florida suggest infection is endemic in Southeast US
August 03, 2023 3 min read Source/Disclosures Published by: Disclosures: Spencer reports no relevant financial disclosures. Please see the study…
Read More » -
Researchers confirm dosing, efficacy of pediatric HIV drug combination
August 03, 2023 2 min read Source/Disclosures Disclosures: Brooks reports receiving consulting fees from ViiV Healthcare. Please see the study…
Read More » -
Increasing COVID vaccine, booster uptake in Black patients requires empathy, conversation
August 01, 2023 1 min read Source/Disclosures Published by: Disclosures: Ezeh reports no relevant financial disclosures. Please see the study…
Read More » -
One in six toddlers did not complete childhood vaccination series before COVID-19
August 02, 2023 3 min read ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on…
Read More » -
NIH picks Marrazzo to replace Fauci as head of NIAID
August 02, 2023 1 min read Source/Disclosures Published by: Disclosures: Tabak reports no relevant financial disclosures. ADD TOPIC TO EMAIL…
Read More » -
Survey shows only 68% of people with hepatitis C aware of the infection
Source/Disclosures Published by: Disclosures: The authors report no relevant financial disclosures. ADD TOPIC TO EMAIL ALERTS Receive an email when…
Read More » -
Women more likely to leave academic medicine; issue ‘needs a systemic solution’
Source/Disclosures Disclosures: Chen and colleagues report no relevant financial disclosures. ADD TOPIC TO EMAIL ALERTS Receive an email when new…
Read More » -
NIH launches clinical trials testing treatments for long COVID symptoms
Source/Disclosures Disclosures: Healio was unable to confirm relevant financial disclosures at the time of publication. ADD TOPIC TO EMAIL ALERTS…
Read More » -
Investigational 21-Valent Pneumococcal Conjugate Vaccine Immunogenic, Safe
Merck’s investigational 21-valent pneumococcal conjugate vaccine, V116, elicited positive immune responses in vaccine-naïve and previously vaccinated individuals, according to results…
Read More »